A Phase 3 Study in Participants With Moderate to Severe Psoriasis
Clinical trial NCT01474512 · COMPLETED
Trial details
- NCT number
- NCT01474512
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-16
- Primary completion
- 2014-06-24
- Enrollment
- 1296
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.